Effects of Transverse Abdominis Plane Block Guided by Ultrasound on the Postoperative Analgesia and Quality of Lives Among the Patients Undergo Inguinal Hernia Repair
Post-operative Pain, Inguinal Hernia
About this trial
This is an interventional treatment trial for Post-operative Pain focused on measuring anesthesia, transverse abdominis plane block, patient controlled intravenous analgesia
Eligibility Criteria
Inclusion Criteria:
- clinical diagnosis of inguinal hernia and will receive open inguinal hernia repair (UHS mesh)
- men or woman and 18 ~ 80 years old
Exclusion Criteria:
- body mass index≤18 or≥35
- American Society of Anesthesiology (ASA) classification of anesthesia risk IV and V grade
- allergic to local anesthetics
- hepatic or renal failure
- being pregnant
- skin infection at the puncture site
- pre-operative opioid or non-steroidal anti-inflammatory drugs treatment for chronic pain
- addicted to drugs or alcohol
- uncontrolled general infection
- femoral hernia, incisional hernia or other special types of hernia
Sites / Locations
- the first affiliated hospital of Chongqing medical university
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
TAPB group
PCIA group
Participants in this group will receive transverse abdominis plane block combined with patient controlled intravenous analgesia.Transverse abdominis plane block will be guided by ultrasound and 0.75% 20 ml ropivacaine will be injected with the sonographic view at the end of the surgery.Participants in this group will also receive patient controlled intravenous analgesia after surgery,the regimens of patient controlled intravenous analgesia are included tramadol 800 mg, flurbiprofenaxetil 100 mg, and dexamethasone 5 mg with saline added up to a volume of 80 ml in total
Participants in this group will only receive patient controlled intravenous analgesia after surgery.The formula of the PCIA included tramadol 800 mg, flurbiprofenaxetil 100 mg, and dexamethasone 5 mg with saline added up to a volume of 80 ml in total, they received a loading dose of 2 ml followed by an infusion rate of 1 ml/h with bolus of 2 ml, the lock time was set at 15 min